Trial NCT02679131

View at ClinicalTrials.gov 
Org. Study IDs: SPI-BEL-105

Last trial update was posted on 2019-11-20

MeSH Interventions

Belinostat

MeSH Conditions

Hematologic Neoplasms Neoplasms Renal Insufficiency

Other Conditions

Relapsed/Refractory Solid Tumors/Hematological Malignancies

Stopping Reasons

Close out study w/o Cohort D; Severe Impairment (eGFR=15 to <30mL/min/1.73m²)

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID